Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)

• Company Description    Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark. Number of Employees: 335

• Price / Volume Information    Yesterday's Closing Price: $72.00 Daily Weekly Monthly 20 Day Moving Average: 130 shares Shares Outstanding: 71.02 (millions) Market Capitalization: $5,113.73 (millions) Beta: 0.74 52 Week High: $126.00 52 Week Low: $49.98 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.57% -0.45% 12 Week 36.44% 28.36% Year To Date -29.66% -38.60%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Sydmarken 11 Soborg - Copenhagen,G7 2860 DNK ph: 45-8877-3600 fax: 45-8877-3898 investors@zealandpharma.com http://www.zealandpharma.com

• General Corporate Information    Officers Adam Steensberg - Chief Executive Officer and President Martin Nicklasson - Chairman of the Board of Directors Ivan Moller - Executive Vice President;Chief Operating Officer Henriette Wennicke - Executive Vice President and Chief Financial Offic Bernadette Connaughton - Director Peer Information Zealand Pharma A/S (CORR.) Zealand Pharma A/S (RSPI) Zealand Pharma A/S (CGXP) Zealand Pharma A/S (BGEN) Zealand Pharma A/S (GTBP) Zealand Pharma A/S (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: K9898X127 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 71.02 Most Recent Split Date: (:1) Beta: 0.74 Market Capitalization: $5,113.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.62 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $14.40 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: 5.00 Trailing 12 Months: 5.06 PEG Ratio: - Price Ratios Price/Book: 2.15 Price/Cash Flow: - Price / Sales: 3.69 EPS Growth vs. Year Ago Period: 2,497.01% vs. Previous Quarter: 2,497.01% Sales Growth vs. Year Ago Period: 27,961.12% vs. Previous Quarter: 121,022.70% ROE 09/30/25 - - 06/30/25 - 67.06 03/31/25 - -13.40 ROA 09/30/25 - - 06/30/25 - 61.12 03/31/25 - -12.28 Current Ratio 09/30/25 - - 06/30/25 - 15.09 03/31/25 - 25.10 Quick Ratio 09/30/25 - - 06/30/25 - 15.08 03/31/25 - 25.07 Operating Margin 09/30/25 - - 06/30/25 - 73.90 03/31/25 - -2,127.09 Net Margin 09/30/25 - - 06/30/25 - 73.90 03/31/25 - -2,127.09 Pre-Tax Margin 09/30/25 - - 06/30/25 - 79.78 03/31/25 - -2,136.10 Book Value 09/30/25 - - 06/30/25 - 33.43 03/31/25 - 16.51 Inventory Turnover 09/30/25 - - 06/30/25 - -0.65 03/31/25 - 0.64 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.02 03/31/25 - 0.03 Debt-to-Capital 09/30/25 - - 06/30/25 - 1.85 03/31/25 - 3.37

Powered by Zacks Investment Research ©